Globus Medical
GMED
596 hedge funds and large institutions have $9.43B invested in Globus Medical in 2026 Q2 according to their latest regulatory filings, with 82 funds opening new positions, 251 increasing their positions, 181 reducing their positions, and 86 closing their positions.
440% more call options, than puts
Call options by funds: $39.1M | Put options by funds: $7.24M
39% more repeat investments, than reductions
Existing positions increased: 251 | Existing positions reduced: 181
6.67% more ownership
Funds ownership: 80.97% → 87.64% (+6.7%)
0% less capital invested
Capital invested by funds: $9.43B → $9.43B (-$1.59M)
5% less first-time investments, than exits
New positions opened: 82 | Existing positions closed: 86
2% less funds holding
Funds holding: 607 → 596 (-11)
42% less funds holding in top 10
Funds holding in top 10: 19 → 11 (-8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$364M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
+$132M |
| 3 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$97.2M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$68.3M |
| 5 |
QCM
Quantinno Capital Management
New York
|
+$57.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$167M |
| 2 |
Millennium Management
New York
|
-$137M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$68.9M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$61.6M |
| 5 |
HRCM
Hawk Ridge Capital Management
Los Angeles,
California
|
-$43.1M |
GMED Hedge Fund Activity: Q2 2026 in Review
596 of the 8,300 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q2 2026, worth a combined $9.43B — down 0.02% from $9.43B a quarter earlier.
Sellers outnumbered buyers: 86 funds closed out of GMED and 82 opened new positions — a net loss of 4 holders — while 181 trimmed existing stakes and 251 added.
The largest buyer was Kayne Anderson Rudnick Investment Management, opening a new position worth an estimated $364M. The largest seller was Citadel Advisors, exiting entirely with an estimated $167M sold.
- 596 institutional investors held Globus Medical (GMED) as of Q2 2026, down from 607 in Q1 2026.
- Funds reported $9.43B of Globus Medical stock for Q2 2026, down 0.02% quarter-over-quarter.
- 82 funds opened new Globus Medical positions in Q2 2026 and 86 closed out, a net change of -4 holders.
- The largest Globus Medical buyer in Q2 2026 was Kayne Anderson Rudnick Investment Management, an estimated $364M added.
- The largest Globus Medical seller in Q2 2026 was Citadel Advisors, an estimated $167M sold.
Based on aggregated 13F filings for Q2 2026.